Status:
UNKNOWN
Applying Web Technology to Buprenorphine Treatment
Lead Sponsor:
National Development and Research Institutes, Inc.
Conditions:
Adult Opioid-Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to examine the efficacy and cost-effectiveness of an interactive, computer-based psychoeducational system when used by opioid-dependent patients in office-based b...
Detailed Description
The partial opioid agonist, buprenorphine, was recently approved by the FDA for the treatment of opioid-dependence and will be available via physician prescription, enabling a greatly needed expansion...
Eligibility Criteria
Inclusion
- Opioid dependence
- Adults ( \>/= 18 years)
- In first month of office-based buprenorphine maintenance treatment
Exclusion
- In buprenorphine-assisted taper
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00182598
Start Date
December 1 2004
Last Update
August 13 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Steven Lee
New York, New York, United States, 10011
2
Dr. Tania Taubes
New York, New York, United States, 10023